361 related articles for article (PubMed ID: 25973911)
1. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
2. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome.
Ng AP; Hyland CD; Metcalf D; Carmichael CL; Loughran SJ; Di Rago L; Kile BT; Alexander WS
Blood; 2010 May; 115(19):3966-9. PubMed ID: 20007548
[TBL] [Abstract][Full Text] [Related]
3. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
4. Transient myeloproliferative disorder with partial trisomy 21.
Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
[TBL] [Abstract][Full Text] [Related]
5. Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.
Birger Y; Goldberg L; Chlon TM; Goldenson B; Muler I; Schiby G; Jacob-Hirsch J; Rechavi G; Crispino JD; Izraeli S
Blood; 2013 Aug; 122(6):988-98. PubMed ID: 23719302
[TBL] [Abstract][Full Text] [Related]
6. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
[TBL] [Abstract][Full Text] [Related]
7. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
[TBL] [Abstract][Full Text] [Related]
8. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Klusmann JH; Li Z; Böhmer K; Maroz A; Koch ML; Emmrich S; Godinho FJ; Orkin SH; Reinhardt D
Genes Dev; 2010 Mar; 24(5):478-90. PubMed ID: 20194440
[TBL] [Abstract][Full Text] [Related]
9. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
[TBL] [Abstract][Full Text] [Related]
10. ERG is a megakaryocytic oncogene.
Salek-Ardakani S; Smooha G; de Boer J; Sebire NJ; Morrow M; Rainis L; Lee S; Williams O; Izraeli S; Brady HJ
Cancer Res; 2009 Jun; 69(11):4665-73. PubMed ID: 19487285
[TBL] [Abstract][Full Text] [Related]
11. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.
Stankiewicz MJ; Crispino JD
Blood; 2009 Apr; 113(14):3337-47. PubMed ID: 19168790
[TBL] [Abstract][Full Text] [Related]
12. Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities.
Banno K; Omori S; Hirata K; Nawa N; Nakagawa N; Nishimura K; Ohtaka M; Nakanishi M; Sakuma T; Yamamoto T; Toki T; Ito E; Yamamoto T; Kokubu C; Takeda J; Taniguchi H; Arahori H; Wada K; Kitabatake Y; Ozono K
Cell Rep; 2016 May; 15(6):1228-41. PubMed ID: 27134169
[TBL] [Abstract][Full Text] [Related]
13. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.
Alford KA; Slender A; Vanes L; Li Z; Fisher EM; Nizetic D; Orkin SH; Roberts I; Tybulewicz VL
Blood; 2010 Apr; 115(14):2928-37. PubMed ID: 20154221
[TBL] [Abstract][Full Text] [Related]
14. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
15. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
Shim KS; Ferrando-Miguel R; Lubec G
J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
[TBL] [Abstract][Full Text] [Related]
16. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
Carpenter E; Valverde-Garduno V; Sternberg A; Mitchell C; Roberts I; Vyas P; Vora A
Br J Haematol; 2005 Feb; 128(4):548-51. PubMed ID: 15686466
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
Tunstall-Pedoe O; Roy A; Karadimitris A; de la Fuente J; Fisk NM; Bennett P; Norton A; Vyas P; Roberts I
Blood; 2008 Dec; 112(12):4507-11. PubMed ID: 18689547
[TBL] [Abstract][Full Text] [Related]
18. The impact of trisomy 21 on foetal haematopoiesis.
Roberts I; O'Connor D; Roy A; Cowan G; Vyas P
Blood Cells Mol Dis; 2013 Dec; 51(4):277-81. PubMed ID: 23932236
[TBL] [Abstract][Full Text] [Related]
19. Trisomy 21 enhances human fetal erythro-megakaryocytic development.
Chou ST; Opalinska JB; Yao Y; Fernandes MA; Kalota A; Brooks JS; Choi JK; Gewirtz AM; Danet-Desnoyers GA; Nemiroff RL; Weiss MJ
Blood; 2008 Dec; 112(12):4503-6. PubMed ID: 18812473
[TBL] [Abstract][Full Text] [Related]
20. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.
De Vita S; Canzonetta C; Mulligan C; Delom F; Groet J; Baldo C; Vanes L; Dagna-Bricarelli F; Hoischen A; Veltman J; Fisher EM; Tybulewicz VL; Nizetic D
Oncogene; 2010 Nov; 29(46):6102-14. PubMed ID: 20697343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
